FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  	OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

Welch David F	2. Issuer Name and Ticker or Trading Symbol

INFINERA CORP [ INFN ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President	
(Last)          (First)          (Middle)

C/O INFINERA CORPORATION, 140 CASPIAN COURT	3. Date of Earliest Transaction (MM/DD/YYYY)

9/22/2014		
(Street)

SUNNYVALE, CA 94089
(City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)

 	6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1.Title of Security
(Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code
(Instr. 8)	4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)	
			Code	V	Amount	(A) or (D)	Price				
Common Stock  	9/22/2014  	 	S (13)	  	7500  	D	$11.2132   (14)	305217  	I  	See Footnote   (2)	
Common Stock  	9/22/2014  	 	S (15)	  	15000  	D	$11.1895   (16)	425000  	I  	See Footnote   (4)	
Common Stock  	 	 	 	  	 	 	 	319493  	I  	See Footnote   (1)	
Common Stock  	 	 	 	  	 	 	 	553750  	I  	See Footnote   (3)	
Common Stock  	 	 	 	  	 	 	 	2500  	I  	See Footnote   (5)	
Common Stock  	 	 	 	  	 	 	 	14132  	D  	 	

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code
(Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)	8. Price of Derivative Security
(Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					
Employee Stock Option (Right to Buy)  	$2  	 	 	   	  	  	  	  (6)	8/8/2016  	Common Stock  	50000  	 	50000  	D  	 	
Employee Stock Option (Right to Buy)  	$2  	 	 	   	  	  	  	  (6)	8/8/2016  	Common Stock  	137500  	 	137500  	D  	 	
Employee Stock Option (Right to Buy)  	$8.19  	 	 	   	  	  	  	  (6)	11/23/2016  	Common Stock  	75000  	 	75000  	D  	 	
Employee Stock Option (Right to Buy)  	$7.61  	 	 	   	  	  	  	  (6)	6/6/2017  	Common Stock  	29214  	 	29214  	D  	 	
Employee Stock Option (Right to Buy)  	$7.61  	 	 	   	  	  	  	  (6)	6/6/2017  	Common Stock  	101342  	 	101342  	D  	 	
Employee Stock Option (Right to Buy)  	$7.61  	 	 	   	  	  	  	  (6)	2/28/2018  	Common Stock  	2817  	 	2817  	D  	 	
Employee Stock Option (Right to Buy)  	$7.61  	 	 	   	  	  	  	  (6)	2/28/2018  	Common Stock  	81683  	 	81683  	D  	 	
Employee Stock Option (Right to Buy)  	$7.11  	 	 	   	  	  	  	  (6)	2/10/2019  	Common Stock  	100000  	 	100000  	D  	 	
Employee Stock Option (Right to Buy)  	$7.45  	 	 	   	  	  	  	  (6)	8/10/2019  	Common Stock  	150000  	 	150000  	D  	 	
Employee Stock Option (Right to Buy)  	$8.58  	 	 	   	  	  	  	  (6)	2/10/2021  	Common Stock  	20250  	 	20250  	D  	 	
Employee Stock Option (Right to Buy)  	$8.58  	 	 	   	  	  	  	  (6)	2/10/2021  	Common Stock  	60750  	 	60750  	D  	 	
Employee Stock Option (Right to Buy)  	$8.58  	 	 	   	  	  	  	  (6)	2/10/2021  	Common Stock  	39465  	 	39465  	D  	 	
Employee Stock Option (Right to Buy)  	$8.58  	 	 	   	  	  	  	  (6)	2/10/2021  	Common Stock  	41535  	 	41535  	D  	 	
Restricted Stock Units  	  (7)	 	 	   	  	  	  	  (8)	  (8)	Common Stock  	26333  	 	26333  	D  	 	
Restricted Stock Units  	  (7)	 	 	   	  	  	  	  (9)	  (9)	Common Stock  	71250  	 	71250  	D  	 	
Restricted Stock Units  	  (7)	 	 	   	  	  	  	  (10)	  (10)	Common Stock  	40000  	 	40000  	D  	 	
Restricted Stock Units  	  (7)	 	 	   	  	  	  	  (11)	  (11)	Common Stock  	36000  	 	36000  	D  	 	
Restricted Stock Units  	  (7)	 	 	   	  	  	  	  (12)	  (12)	Common Stock  	62770  	 	62770  	D  	 	

Explanation of Responses:	
(  1) 	These shares are held directly by LRFA, LLC, for which Dr. Welch is the sole managing member.	
(  2) 	These shares are held directly by The Welch Family Trust u/a dtd 04/03/1996 ("The Welch Family Trust").	
(  3) 	These shares are held directly by SEI Private Trust Company, Trustee of The Welch Family Heritage Trust I u/I dated 9/24/01.	
(  4) 	These shares are held directly by The Welch Group, L.P., for which Dr. Welch is the general partner ("The Welch Group").	
(  5) 	These shares are held directly by Dr. Welch as a trustee for his children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his children for purposes of Section 16 or for any other purpose.	
(  6) 	This option is fully-vested.	
(  7) 	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company").	
(  8) 	These RSUs vest in three annual installments beginning on February 5, 2013.	
(  9) 	These RSUs fully vest on December 31, 2014.	
(  10) 	These RSUs vest in three annual installments beginning on February 5, 2014.	
(  11) 	These RSUs vest in four annual installments beginning on August 5, 2014.	
(  12) 	These RSUs vest in three annual installments beginning on May 5, 2015.	
(  13) 	This sale was made in connection with the Rule 10b5-1 Trading Plan for The Welch Family Trust, which was adopted on May 29, 2014.	
(  14) 	This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $11.12 to $11.29 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.	
(  15) 	This sale was made in connection with the Rule 10b5-1 Trading Plan for The Welch Group, which was adopted on May 29, 2014.	
(  16) 	This price represents the weighted average sale price of the shares sold in multiple transactions at prices ranging from $11.10 to $11.29 per share. Upon request by the staff of the Securities and Exchange Commission, the Company or a security holder of the Company, Dr. Welch will provide full information regarding the number of shares sold at each separate price.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
Welch David F
C/O INFINERA CORPORATION
140 CASPIAN COURT
SUNNYVALE, CA 94089	X		President		

Signatures		
/s/ Michael Post, by Power of Attorney		9/24/2014	
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.